DEVELOPMENT AND COMMERCIALIZATION AGREEMENTDevelopment and Commercialization Agreement • August 12th, 2013 • Array Biopharma Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 12th, 2013 Company Industry JurisdictionThis Development and Commercialization Agreement (the “Agreement”), entered into as of May 29, 2013 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having offices at 3200 Walnut Street, Boulder, Colorado 80301, and Oncothyreon Inc., a Delaware corporation, having offices at with offices at 2601 Fourth Ave., Suite 500, Seattle WA 98121.
ARTICLE 1DRUG DISCOVERY COLLABORATION AGREEMENTDiscovery Collaboration Agreement • August 12th, 2013 • Array Biopharma Inc • Pharmaceutical preparations • New York
Contract Type FiledAugust 12th, 2013 Company Industry JurisdictionThis DRUG DISCOVERY COLLABORATION AGREEMENT (the “Agreement”), effective as of July 3, 2013 (the “Effective Date”), is made by and between Array BioPharma Inc., a Delaware corporation, having a principal place of business at 3200 Walnut Street, Boulder, Colorado 80301 (“Array”), and Loxo Oncology, Inc., a Delaware corporation, having an address at c/o Aisling Capital, 888 7th Avenue, 30th Floor, New York, New York 10106 (“Loxo”).